We are live on ! Find out more
MYOV

Myovant Sciences Ltd.

Delisted

MYOV was delisted on the 9th of March, 2023.

35 hedge funds and large institutions have $490M invested in Myovant Sciences Ltd. in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 3

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

43% more capital invested

Capital invested by funds: $342M → $490M (+$148M)

13% more funds holding

Funds holding: 3135 (+4)

Holders
35
Holders Change
+4
Holders Change %
+12.9%
% of All Funds
0.8%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
9
Increased
15
Reduced
3
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BB
1
BB Biotech
Switzerland
$94.7M +$1.36M +60,000 +2%
RCM
2
RA Capital Management
Massachusetts
$91.6M +$14.1M +621,404 +22%
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$67M +$31.7M +1,401,796 +125%
EAM
4
Eventide Asset Management
Massachusetts
$56.2M +$11.6M +513,339 +32%
Lord, Abbett & Co
5
Lord, Abbett & Co
New Jersey
$50.4M +$16.6M +734,870 +63%
NCM
6
NovaQuest Capital Management
North Carolina
$31.6M
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$21.5M +$3.05M +134,677 +20%
Norges Bank
8
Norges Bank
Norway
$19.9M +$3.39M +150,000 +25%
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$19.2M +$566K +25,000 +4%
Millennium Management
10
Millennium Management
New York
$10.6M +$4.73M +208,927 +109%
RSCM
11
Rock Springs Capital Management
Maryland
$9.23M +$1.19M +52,400 +18%
BAMCO Inc
12
BAMCO Inc
New York
$3.52M +$1.69M +74,561 +128%
EU
13
Emory University
Georgia
$3.37M +$84.8K +3,745 +3%
JP Morgan Chase
14
JP Morgan Chase
New York
$2.43M -$726K -32,068 -26%
PIM
15
Platinum Investment Management
Australia
$1.9M +$389K +17,200 +32%
State Street
16
State Street
Massachusetts
$1.24M
Morgan Stanley
17
Morgan Stanley
New York
$1.07M +$482K +21,306 +113%
Northern Trust
18
Northern Trust
Illinois
$792K +$675K +29,847 New
Swiss National Bank
19
Swiss National Bank
Switzerland
$751K
BlackRock
20
BlackRock
New York
$705K -$11.8M -521,074 -95%
Lazard Asset Management
21
Lazard Asset Management
New York
$675K +$248K +10,954 +76%
MC
22
Matisse Capital
Oregon
$405K
Bank of New York Mellon
23
Bank of New York Mellon
New York
$315K
WAM
24
Weiss Asset Management
Massachusetts
$254K
Two Sigma Investments
25
Two Sigma Investments
New York
$202K +$172K +7,593 New

MYOV Hedge Fund Activity: Q3 2018 in Review

35 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q3 2018, worth a combined $490M — up 43% from $342M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new MYOV positions and 5 closed out — a net gain of 4 holders — while 15 added to existing stakes and 3 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $31.7M. The largest seller was BlackRock, cutting an estimated $11.8M.

  • 35 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q3 2018, up from 31 in Q2 2018.
  • Funds reported $490M of Myovant Sciences Ltd. stock for Q3 2018, up 43% quarter-over-quarter.
  • 9 funds opened new Myovant Sciences Ltd. positions in Q3 2018 and 5 closed out, a net change of +4 holders.
  • The largest Myovant Sciences Ltd. buyer in Q3 2018 was Janus Henderson Group, an estimated $31.7M added.
  • The largest Myovant Sciences Ltd. seller in Q3 2018 was BlackRock, an estimated $11.8M sold.

Based on aggregated 13F filings for Q3 2018.